NASDAQ · Drug Manufacturers - Specialty & Generic
Esperion Therapeutics Inc (ESPR)
$3.18
0.00%
43
In band
Moving averages
SMA 200$3.08+3.25%
Company profile
Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$819.47M
Beta1.064
52-week high$4.18
52-week low$1.11
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 45
CGC
Canopy Growth Corporation
RSI 46
BFRI
Biofrontera Inc
RSI 67
TLRY
Tilray Brands Inc - Class 2
RSI 49
LNTH
Lantheus Holdings Inc
RSI 48
ACB
Aurora Cannabis Inc
RSI 75
BCRX
Biocryst Pharmaceuticals Inc
RSI 50
INM
InMed Pharmaceuticals Inc
RSI 37
ORGO
Organogenesis Holdings Inc - Class A
RSI 34
ZTS
Zoetis Inc - Class A
RSI 57
RSI alerts for ESPR
Get an email the moment Esperion Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 2:02 AM EDT